Informatie:
Fout:
ID
32693
Beschrijving
Study ID: 107038 Clinical Study ID: LPL107038 Study Title: Study to Estimate the Dose Proportionality of the Enteric-Coated Freebase Formulation of SB-480848 Patient Level Data: Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: Tyrisa ,US Study Indication: Atherosclerosis
Trefwoorden
Versies (1)
- 12-11-18 12-11-18 -
Houder van rechten
GSK group of companies
Geüploaded op
12 november 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Estimation of Dose Proportionality of Darapladib - 107038
Pharmacodynamics Post Dose Data - [Analyte and PD sample type]
- StudyEvent: ODM
Similar models
Pharmacodynamics Post Dose Data - [Analyte and PD sample type]
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Dosing date
Item
Dosing date
date
Dosing time
Item
Dosing time
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Date of sample
Item
Date of sample
date
Time of sample
Item
Time of sample
time
Date of sample
Item
Date of sample
date
Time of sample
Item
Time of sample
time
Date of sample
Item
Date of sample
date
Time of sample
Item
Time of sample
time